全文获取类型
收费全文 | 148166篇 |
免费 | 32418篇 |
国内免费 | 2391篇 |
专业分类
耳鼻咽喉 | 5168篇 |
儿科学 | 5358篇 |
妇产科学 | 2385篇 |
基础医学 | 2993篇 |
口腔科学 | 1488篇 |
临床医学 | 26520篇 |
内科学 | 46809篇 |
皮肤病学 | 7395篇 |
神经病学 | 14639篇 |
特种医学 | 6338篇 |
外科学 | 40746篇 |
综合类 | 241篇 |
现状与发展 | 72篇 |
一般理论 | 1篇 |
预防医学 | 6952篇 |
眼科学 | 3320篇 |
药学 | 896篇 |
中国医学 | 10篇 |
肿瘤学 | 11644篇 |
出版年
2024年 | 514篇 |
2023年 | 4789篇 |
2022年 | 1158篇 |
2021年 | 3071篇 |
2020年 | 6017篇 |
2019年 | 2152篇 |
2018年 | 7362篇 |
2017年 | 7314篇 |
2016年 | 8388篇 |
2015年 | 8378篇 |
2014年 | 15442篇 |
2013年 | 15547篇 |
2012年 | 5362篇 |
2011年 | 5361篇 |
2010年 | 10291篇 |
2009年 | 14173篇 |
2008年 | 5688篇 |
2007年 | 3920篇 |
2006年 | 6389篇 |
2005年 | 3674篇 |
2004年 | 2953篇 |
2003年 | 1925篇 |
2002年 | 2015篇 |
2001年 | 3783篇 |
2000年 | 2999篇 |
1999年 | 3196篇 |
1998年 | 3628篇 |
1997年 | 3452篇 |
1996年 | 3355篇 |
1995年 | 3195篇 |
1994年 | 1938篇 |
1993年 | 1568篇 |
1992年 | 1355篇 |
1991年 | 1414篇 |
1990年 | 1056篇 |
1989年 | 1175篇 |
1988年 | 1014篇 |
1987年 | 837篇 |
1986年 | 886篇 |
1985年 | 717篇 |
1984年 | 543篇 |
1983年 | 514篇 |
1982年 | 508篇 |
1981年 | 392篇 |
1980年 | 355篇 |
1979年 | 308篇 |
1978年 | 329篇 |
1977年 | 396篇 |
1975年 | 279篇 |
1972年 | 280篇 |
排序方式: 共有10000条查询结果,搜索用时 447 毫秒
61.
Sebastian P. Mondaca MD Dazhi Liu PharmD BCOP Jessica R. Flynn Sandy Badson Stefan Hamaway BS Mrinal M. Gounder MD Danny N. Khalil MD PhD Alexander E. Drilon MD Bob T. Li MD MPH Komal L. Jhaveri MD Alison M. Schram MD Katherine E. Kargus RN Mary Kate Kasler DNP MSN Natalie M. Blauvelt Neil H. Segal MD PhD Marinela Capanu PhD Margaret K. Callahan MD PhD David M. Hyman MD Maya Gambarin-Gelwan MD James J. Harding MD 《Cancer》2020,126(22):4967-4974
62.
63.
64.
Breast Elastography: How to Perform and Integrate Into a “Best-Practice” Patient Treatment Algorithm
Breast elastography has been available for more than 15 years but is not widely incorporated into clinical practice. Many publications report extremely high accuracy for various breast elastographic techniques. However, results in the literature are extremely variable. This variability is most likely due to variations in technique, a relatively steep learning curve, and variability in methods between vendors. This article describes our protocol for performing breast elastography using both strain elastography and shear wave elastography, which produces high sensitivity and specificity. Additionally, we will describe the most commonly known false-positive and false-negative lesions as well as how to detect them. 相似文献
65.
The term “oligometastatic prostate cancer” refers to a heterogeneous group of disease states currently defined solely on the basis of clinical features. Oligorecurrent disease, de novo oligometastases, and oligoprogressive disease likely have unique biologic underpinnings and natural histories. Evidence suggesting the existence of a subset of patients who harbor prostate cancer with limited metastatic potential currently includes disparate and overwhelmingly retrospective reports. Nevertheless, emerging prospective data have corroborated the “better-than-expected,” retrospectively observed outcomes, particularly in the setting of oligorecurrent prostate cancer. Improved functional imaging with prostate-specific membrane antigen-targeted strategies may enhance the identification of patients with oligometastatic prostate cancer in the short term. In the long term, refinement of the oligometastatic case definition likely will require biologic risk-stratification schemes. To determine optimal treatment strategies and identify patients most likely to benefit from metastasis-directed therapy, future efforts should focus on conducting high-quality, prospective trials with much-needed molecular correlative studies. 相似文献
66.
67.
68.
Huda Mohammed Alkreathy Mayson H. Alkhatib Safaa Ahmed Al Musaddi Khadijah Saeed A. Balamash Nadia Nour Osman Aftab Ahmad 《Clinical and experimental pharmacology & physiology》2019,46(5):496-505
Doxorubicin (DOX) is the most commonly used anticancer drug; however, it has limited use because prolonged administration may result in severe cardiotoxicity. Simvastatin (SIM), generally prescribed for hypercholesterolaemia, has also shown salubrious results in the monotherapy or combinational drug therapy of different cancers in various models. Nanoparticle drug delivery systems are a novel way of improving therapeutics and also improving the absorption and specificity of drugs towards tumour cells. In this study, we exploited this technology to increase drug specificity and minimize imminent adverse effects. In this study, the antitumour activity of the combination formulas of DOX and SIM, either loaded in water (DOX‐SIM‐Solution) or nanoemulsions (NEs) (DOX‐SIM‐NE), was evaluated in a Swiss albino mouse model of Ehrlich ascites carcinoma. The anticancer effect was assessed by quantifying the change in body weight, mean survival time, and percent increase in lifespan (%ILS), determining haematological and serum biochemical parameters (liver function test, kidney function test and lipid profile parameters) as well as studying the histopathological alterations in liver tissues. We observed a clear increase in %ILS of the DOX‐SIM‐Solution group (265.30) that was double the %ILS of the DOX‐SIM‐NE group (134.70). However, DOX‐SIM‐NE had a non‐toxic effect on the haematological parameters, whereas DOX‐SIM‐Solution increased the levels of haemoglobin and lymphocytes. Furthermore, the encapsulation of SIM and DOX into NEs improved the levels of all serum biochemical parameters compared to the DOX‐SIM‐Solution. A reduction in the side effects of DOX‐SIM‐NE on the liver was also established using light microscopy, which revealed that the morphologies of the hepatocytes of the mice were less affected by administration of the DOX‐SIM‐NE treatment than with the DOX‐SIM‐Solution treatment. The study showed that incorporating SIM into the DOX‐loaded‐NE formulation remarkably improved its efficiency and simultaneously reduced its adverse effects. 相似文献
69.